CTLA4 and neoplasm: Activated conventional T cells also express CTLA-4, and there is additional evidence shows that respectively blockade of CTLA-4 on either Treg or effector T cells with selective blocking antibodies enhances the anti-tumor immune effect, suggesting that both Treg and effector T cells are relevant targets of anti–CTLA-4 antibodies (35).